Pharmacotherapeutics of SARS-CoV-2 Infections

The COVID-19 pandemic has affected more than 38 million people world-wide by person to person transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therapeutic and preventative strategies for SARS-CoV-2 remains a significant challenge. Within the past several months, effe...

詳細記述

保存先:
書誌詳細
出版年:J Neuroimmune Pharmacol
主要な著者: Kevadiya, Bhavesh D., Machhi, Jatin, Herskovitz, Jonathan, Oleynikov, Maxim D., Blomberg, Wilson R., Bajwa, Neha, Soni, Dhruvkumar, Das, Srijanee, Hasan, Mahmudul, Patel, Milankumar, Senan, Ahmed M., Gorantla, Santhi, McMillan, JoEllyn, Edagwa, Benson, Eisenberg, Robert, Gurumurthy, Channabasavaiah B., Reid, St Patrick M., Punyadeera, Chamindie, Chang, Linda, Gendelman, Howard E.
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2021
主題:
Invited Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7785334/
https://ncbi.nlm.nih.gov/pubmed/33403500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11481-020-09968-x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料